• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market

$995.00 – $7,000.00

Clear
SKU: KLI1340128 Categories: Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 292
  • Description
  • Table of Contents
  • Latest reports

Description

The market for psychotherapeutics drugs is about to change dramatically — and serious pharmaceutical market watchers will want to be prepared. Kalorama’s Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs: World Market is the most exhaustive guide available to this booming market and the direction it is headed in the next four years.

Psychotherapeutics treat conditions classified as abnormal behavior, thoughts and feelings that persist for a determined amount of time causing distress or emotional/physical impairment. Depression, anxiety, psychosis, ADHD and nicotine and drug dependence are among the conditions psychotherapeutics treat. Well-known brands such as Prozac™, Zoloft™ and Ritalin ™ have made this a $37 billion market. And according to Kalorama’s research, revenues from this area will grow more than 50% by 2010.

Antidepressants, Antipsychotics, Antianxiety Drugs, and other Psychotherapeutics: World Marketcovers this market completly including an overview; surveys of the key corporate players, geographic market breakdowns, and revenue forecasts to 2010 in these key market segments:

  • Antidepressants
  • Antipsychotics/Antimanics
  • Antianxiety Drugs
  • Stimulants and Non-stimulants for ADHD
  • Smoking Cessation Drugs, Drug Addiction Treatments, Eating Disorder Treatments and Other Psychotherapeutics

In every category of psychotherapeutics, new competitors are emerging. Kalorama’s report provides profiles of thirty-six new psychotherapeutic drugs in the pipeline, their expected approval status, and how they may shake up the marketplace – as well as a complete discussion of the issues and trends that will effect psychotherapeutics.

The report also includes current issues and trends affecting the industry including the increasing number of additional indications pharma companies are seeking for their brands and success stories in this area.

Over 110 tables and figures clearly demonstrate the current and future psychotherapeutic markets.

As part of our complete coverage, the following companies are profiled:

  • Astellas Pharma, Inc.
  • AstraZeneca Plc
  • Biovail Corporation
  • Bristol-Myers Squibb
  • Eli Lilly & Company
  • Forest Laboratories, Inc.
  • GlaxoSmithKline Plc
  • H. Lundbeck A/S
  • Johnson & Johnson
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer, Inc.
  • Shire Pharmaceuticals Group Plc
  • Wyeth

Kalorama’s trusted information-gathering process provides the most accurate study of the market for anti-depressants, anti-anxiety drugs, ADHD treatments and other psychotherapeutic drugs available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies and in the psychotherapeutics market. While financial reports, major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Product managers, marketing managers, business development executives, advertising agency or investment firm executives, as well as information and research center librarians are among the individuals who will find this survey of the changing psychotherapeutics market essential.

Kalorama’s Antidepressants, Antipsychotics, Antianxiety Drugs, and other Psychotherapeutics: World Market provides coverage of the following brands:

  • Nardil
  • Parnate
  • Prozac
  • Paxil
  • Zoloft
  • Celexa
  • Lexapro
  • Effexor and Effexor XR
  • Cymbalta
  • Wellbutrin and Wellbutrin XL and Wellbutrin SR
  • Serzone
  • Desyrel
  • Remeron
  • Symbyax
  • Tolvon
  • Xanax
  • Ativan
  • Klonopin
  • Valium
  • Versed
  • BuSpar
  • Lexotan
  • Paxil/Seroxat and Paxil CR
  • Zoloft
  • Ritalin
  • Focalin and Focalin XR
  • Daytrana
  • Strattera
  • Concerta
  • Metadate CD
  • Adderall and Adderall XR
  • Chantix/Champix
  • Zyban
  • Accomplia
  • Nicotrol
  • Subutex
  • Campral
  • Methodone
  • ReVia/Naltrex
  • Antabuse
  • Narcan
  • Vivitrol
  • Depade
  • YAZ
  • SSRIs
  • Compazine, Serentil, Stelazine, Thorazine
  • Geodon
  • Zyprexa
  • Risperdal, Risperdal Consta
  • Clozaril
  • Seroquel
  • Abilify
  • Lithobid, Eskalith
  • Symbyax
  • Lamictal
  • EMSAM

Table of Contents

    Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals
    May 22, 2023
    Precision Cancer Therapeutics Market, 2022
    October 25, 2022
    The World Market for Vaccines, 2022-2027
    September 23, 2022
    Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
    August 2, 2022

Related products

  • Placeholder image

    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    $3,500.00 – $7,000.00
  • Placeholder image

    Advanced Drug Delivery: Technologies, Applications, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    Drug Delivery Technology and Applications: A summary of Kalorama’s market research, 2001-2003

    $746.00 – $1,492.00
  • Placeholder image

    Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline

    $3,500.00 – $7,000.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Global Medtech Sales Exceed $500 Billion as Chronic Diseases Shape Market’s Future November 14, 2023
  • Healthcare Advances, Investments Support Laboratory Information System (LIS) Growth October 26, 2023
  • Personalized Medicine Key to IVD Procedure Volumes’ 10% Annual Growth October 19, 2023
  • RNA Sequencing: Life Sciences’ Transformative $2.6 Billion Industry October 4, 2023
  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Clinical Diagnostics in India – Market Sector Analyses and Participant...Worldwide Market for Dialysis Equipment, Supplies, and Services, 2nd Edition,...
Scroll to top